<analysis>
**Action 1 (checkpoint 3 defaults to a pause).**
- **What is easy:** Redwood is independent. It can file an OSF amendment in its own name and pre-register the awareness tally with little friction.
- **What is hard:**
  - The amendment binds nothing unless the RSO treats it as part of the stop rule. Counsel has pulled every checkpoint-related Anthropic statement into review for two months running.
  - Holder self-publication is uncertain. UK AISI is unlikely to publish anything on a US model during the OSTP review. METR's publication may be constrained by its access terms with Anthropic.
- **What the P(failure) covers:** counsel neutralising the default-hold, and the holders not being able or willing to publish. Whether a set exists at all is modelled by Threat 1, not here.

**Declared distribution: sealed set for checkpoint 3 (by about 20 March).**
- UK AISI commits as set-author: about 25%. Its officials already balked at the wording, and the OSTP review makes any named role risky.
- METR commits a validated family in time: about 40% of all cases. It has honeypot material from the December and January work, but its own timelines have slipped before.
- No set: about 35%.

**If no set, what happens to training:**
- If Action 1 succeeds, the stop rule **pauses** training at checkpoint 3.
  - About 30% chance the CEO overrides before month-end, disclosed within 72 hours.
  - About 70% chance training stays held into April.
- If Action 1 fails, the rule **mostly lapses** into RSO discretion.
  - About 55% that training proceeds on an internal-only set, with the reading held by counsel.
  - About 45% that the RSO holds anyway.

**Action 2 (board paper).** I draft the paper and the CEO carries it, so delivery is likely. The findings anchor is a management recommendation the board may reject; Threat 3 covers that.

**Declared distribution: board long-stop date at the March meeting.**
- Findings-anchored date (around late June, 60 days after the review): 30%.
- Fixed calendar date around 30 June, not tied to the review: 35%.
- Earlier fixed date (May): 10%.
- Decision deferred to April: 25%.

**Action 3 (unbundled evidence).** METR and Redwood can act themselves.
- The METR dataset and the OpenAI re-request are near-routine.
- The public posting of the definitions could still draw ONCD or counsel attention, because they derive from Anthropic's internal instrumentation.
- The Brookings interim note is plausible.

**Action 4 (reviewer capacity).** Preparing the table and expanding the audit to n=200 is routine. The CEO decides the budget.

**Declared distribution: CEO standing-team decision.**
- Full 14 roles with a surge bridge: 35%.
- Partial (about 7–8 roles, or surge extended only to 30 June): 40%.
- No funding, so the session cut applies on 1 April: 15%.
- Deferred to April: 10%.

**Action 5 (hardening).** It has slipped three months running.
- Pre-booking spring windows helps, but NERC notes spring outages crowd the shoulder season.
- Signature validation with a Health-ISAC allow-list is doable.
- Oklahoma's decision is in April regardless.
- P(failure) covers utility slippage below target.

**Action 6 (jobs and benefits evidence).** A restricted-access data agreement needs a data-use agreement, IRB approval and counsel's view on privilege while *Oyelaran* is live. Signing within March is unlikely. The offer, GFI and DNDi are routine. Partial success means the agreement is in negotiation, not signed.

**Exogenous timing distributions.**
- **K5 weights:** March 20%, April–May 35%, June 25%, slips past H1 20%.
- **Gemini 5 successor:** March 10%, April 30%, May 30%, June 20%, later 10%.

**Capability step:** +0.10–0.12, to about 3.38. This continues the trend from OpenAI's internal automation and the GPT-7 and Gemini training runs, with no named cause to change it.
</analysis>

<action_odds>
Action 1 [Checkpoint 3 default-pause + holder publication]: P(failure) 40%. Reason: Redwood's filing and the tally are easy. But counsel may refuse to let the amendment bind the RSO's rule, and UK AISI or METR self-publication faces access-term and review-politics limits. Set availability is modelled separately in Threat 1.

Action 2 [Findings-anchored staging paper]: P(failure) 25%. Reason: this is an internal paper through existing channels, so delivery is likely. The main risk is management diluting the findings anchor or the METR interim route before it reaches the board. Board rejection of the anchor is Threat 3.

Action 3 [Unbundled evidence deliveries]: P(failure) 25%. Reason: METR and Redwood control most parts and can act themselves. Residual risk is ONCD or counsel friction on posting definitions built from Anthropic's instrumentation, and Brookings's capacity for an interim note.

Action 4 [Reviewer capacity table + n=200 audit]: P(failure) 20%. Reason: preparation and audit expansion are routine. The CEO's choice is the declared distribution, and even partial funding counts as the rule linking capacity to autonomy working.

Action 5 [Spring-window hardening]: P(failure) 40%. Reason: slipped three months running, and spring outages crowd maintenance windows. Signature validation plus the allow-list is feasible within the month.

Action 6 [Restricted-access jobs data]: P(failure) 55%. Reason: a data-use agreement, IRB approval and a privilege review while *Oyelaran* is live rarely close within a month. Partial success means the offer is made and negotiations are underway, while GFI and DNDi continue.
</action_odds>

<threat_odds>
Threat 1 [No sealed set; pause or override becomes the story]: P(materialises) 30%. Adversary suggested 45%. Reason for the difference: METR has reusable honeypot material from the December and January work, and a family built for this purpose is more tractable than the full December battery. UK AISI's refusal is likely but not the only path. If it materialises, the consequences follow the pause, override or lapse distribution declared above.

Threat 2 [Awareness tally reads clean while behaviour differs]: P(materialises) 15%. Adversary suggested 30%. Reason for the difference: it needs checkpoint 3 to run with a set, a published reading, and an outside behavioural differential, all within roughly six days of month-end. The underlying phenomenon is real, but the timing is tight.

Threat 3 [Board picks a calendar date; METR interim route draws objection]: P(materialises) 35%. Adversary suggested 40%. Reason for the difference: director impatience is well evidenced, and ONCD has raised informal concerns twice. The declared board distribution still leaves a real chance of a findings anchor or a deferral.

Threat 4 [Hospital intrusion via the uncovered fork's remote-management gap]: P(materialises) 9%. Adversary suggested 15% for the incident. Reason for the difference: there have been no attributed V7 intrusions in three months of scanning. Attribution to a specific fork within the month is itself uncommon. Indicators ship now. Utility slippage is already priced into Action 5, so it is not counted here.

Threat 5 [K5 weights in March; forks outpace signatures]: P(materialises) 20%. Adversary suggested 30%. Reason for the difference: "H1" spans four more months, and Moonshot has kept K5 API-only since December. I declare March at 20% of the H1 distribution. The data-agreement delay is already in Action 6's P(failure).
</threat_odds>
